🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalSouth Korea Ozempic availability — 12 month update Page 5

South Korea Ozempic availability — 12 month update

greg_boulder Sat, Aug 16, 2025 at 6:58 AM 40 replies 1,750 viewsPage 5 of 8
robert_kc
Member
289
1,234
Oct 2024
Kansas City, MO
Aug 25, 2025 at 10:59 AM#21

A narrower follow-up, since the general answer is now clear:

What would you measure differently if you were starting again?

Last edited: Aug 25, 2025 at 12:59 PM
50 0PurityPaulOR, MaxMetOK, MounjBrad and 47 others
Reply Quote Save Share Report
HealthEcon_DC
Member
567
3,456
Apr 2024
Washington, DC
Aug 26, 2025 at 2:22 PM#22
DeniseRN_TPA said:
The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either.

I am going to disagree with the direction of travel here. The thread has converged on the tidiest answer rather than the best-supported one, and those are not the same thing.

Last edited: Aug 26, 2025 at 4:22 PM
49 24JessicaH_TX, KevinCompounds, TirzTom and 46 others
Reply Quote Save Share Report
Dr.BariatricHTX
Senior Member
1,456
7,234
Feb 2024
Houston, TX
Aug 27, 2025 at 5:46 PM#23
DeniseRN_TPA said:
The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either.

True, and it depends on a baseline nobody has stated. Without knowing where someone started, the same number can be an excellent result or a disappointing one.

Last edited: Aug 27, 2025 at 11:46 PM
48 23Dr.EM_Chicago, pete_RVA, CarlaRPh_TPA and 45 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
EndoResFellow
Member
456
2,345
Sep 2024
Baltimore, MD
Aug 28, 2025 at 9:11 PM#24
DeniseRN_TPA said:
The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either.

Thank you for spelling out the reasoning rather than just the conclusion. I will report back once I have actually tried it.

Last edited: Aug 28, 2025 at 11:11 PM
47 22NurseKim_ATL, paul_denver, TinaHashiRN and 44 others
Reply Quote Save Share Report
PharmHunterJen
Member
567
2,345
Jul 2024
Illinois
Aug 30, 2025 at 12:36 AM#25

From the other side of the consultation, briefly. Worth answering the question that was asked rather than the one behind it. The narrow version usually has an answer; the broad version usually does not, and answering the broad one is how a thread stops being useful.

46 21mike_mealprep, NicoleRaleigh, james_edin and 43 others
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register